Milds Matter—Feasibility of Emicizumab Prophylaxis in Mild Hemophilia

Read full text Summarise with VIRAT
Authors: Kyle Davis, Amy D. Shapiro, Sanjay P. Ahuja
Cited by: 0
References: 8

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

The data that support the findings of this study are available from the corresponding author, [KAD], upon reasonable request.

Fields of Study & Subjects

Hemophilia Treatment and Research Platelet Disorders and Treatments Coagulation Bradykinin Polyphosphates and Angioedema

Publication details

Journal / source
Haemophilia
Volume
32
Issue
4
Pages
1090–1092
Publication date
27 March 2026
Language
EN